Search research articles
Contact Us
Filters
Showing results (1-10 of 27) with videos related to
Page
of 3
Sort By:
Pain Management
|
May 11, 2023
Low back pain management in routine clinical practice: what is important for the individual patient?
Kai-Uwe Kern
Journal of Pain Research
|
September 2, 2017
Ambroxol for the treatment of fibromyalgia: science or fiction?
Kai-Uwe Kern, Myriam Schwickert
Journal of Pain and Symptom Management
|
September 27, 2006
Management of phantom pain with a textile, electromagnetically-acting stump liner: a randomized, double-blind, crossover study
Uwe Kern, Bernd Altkemper, Matthias Kohl
Journal of Pain Research
|
October 29, 2020
Expert Opinion: Exploring the Effectiveness and Tolerability of Capsaicin 179 mg Cutaneous Patch and Pregabalin in the Treatment of Peripheral Neuropathic Pain
Frank Huygen, Kai-Uwe Kern, Concepción Pérez
Pain Practice : the Official Journal of World Institute of Pain
|
December 3, 2013
Treatment of neuropathic pain with the capsaicin 8% patch: is pretreatment with lidocaine necessary?
Kai-Uwe Kern, Walburga Nowack, Chris Poole
American Journal of Physical Medicine & Rehabilitation
|
April 22, 2004
Effects of botulinum toxin type B on stump pain and involuntary movements of the stump
Uwe Kern, Cochita Martin, Sigrun Scheicher, et al.
American Journal of Physical Medicine & Rehabilitation
|
July 19, 2011
Botulinum toxin type B in the treatment of residual limb hyperhidrosis for lower limb amputees: a pilot study
Uwe Kern, Matthias Kohl, Ulrich Seifert, et al.
MMW Fortschritte Der Medizin
|
October 30, 2014
[Tapentadol prolonged release improves analgesia, functional impairment and quality of life in patients with chronic pain who have previously received oxycodone/naloxone]
Kai-Uwe Kern, Doris Krings, Susanne Waldmann-Rex
Journal of Rehabilitation Medicine
|
January 1, 2005
Does botulinum toxin A make prosthesis use easier for amputees?
Uwe Kern, Cochita Martin, Sigrun Scheicher, et al.
MMW Fortschritte Der Medizin
|
April 22, 2022
[Tapentadol versus classical WHO-III opioids for chronic back pain. Health services research study based on representative data from health insurance funds]
Kai-Uwe Kern, Tobias Vogelmann, Thomas R Tölle
Page
of 3
Search research articles
Search
Showing results (1-10 of 27) with videos related to
Sort By:
Page
of 3
Pain Management
|
May 11, 2023
Low back pain management in routine clinical practice: what is important for the individual patient?
Kai-Uwe Kern
Journal of Pain Research
|
September 2, 2017
Ambroxol for the treatment of fibromyalgia: science or fiction?
Kai-Uwe Kern, Myriam Schwickert
Journal of Pain and Symptom Management
|
September 27, 2006
Management of phantom pain with a textile, electromagnetically-acting stump liner: a randomized, double-blind, crossover study
Uwe Kern, Bernd Altkemper, Matthias Kohl
Journal of Pain Research
|
October 29, 2020
Expert Opinion: Exploring the Effectiveness and Tolerability of Capsaicin 179 mg Cutaneous Patch and Pregabalin in the Treatment of Peripheral Neuropathic Pain
Frank Huygen, Kai-Uwe Kern, Concepción Pérez
Pain Practice : the Official Journal of World Institute of Pain
|
December 3, 2013
Treatment of neuropathic pain with the capsaicin 8% patch: is pretreatment with lidocaine necessary?
Kai-Uwe Kern, Walburga Nowack, Chris Poole
American Journal of Physical Medicine & Rehabilitation
|
April 22, 2004
Effects of botulinum toxin type B on stump pain and involuntary movements of the stump
Uwe Kern, Cochita Martin, Sigrun Scheicher, et al.
American Journal of Physical Medicine & Rehabilitation
|
July 19, 2011
Botulinum toxin type B in the treatment of residual limb hyperhidrosis for lower limb amputees: a pilot study
Uwe Kern, Matthias Kohl, Ulrich Seifert, et al.
MMW Fortschritte Der Medizin
|
October 30, 2014
[Tapentadol prolonged release improves analgesia, functional impairment and quality of life in patients with chronic pain who have previously received oxycodone/naloxone]
Kai-Uwe Kern, Doris Krings, Susanne Waldmann-Rex
Journal of Rehabilitation Medicine
|
January 1, 2005
Does botulinum toxin A make prosthesis use easier for amputees?
Uwe Kern, Cochita Martin, Sigrun Scheicher, et al.
MMW Fortschritte Der Medizin
|
April 22, 2022
[Tapentadol versus classical WHO-III opioids for chronic back pain. Health services research study based on representative data from health insurance funds]
Kai-Uwe Kern, Tobias Vogelmann, Thomas R Tölle
Page
of 3